MEN syndrome

MEN = Multiple Endocrine Neoplasia Syndrome' - this includes three syndromes, the main components of which are tumors of the endocrine glands.

Definition and Epidemiology
Autosomal dominant hereditary syndrome with a prevalence of 2-20 cases per 100,000 population characterized mainly by primary hyperparathyroidism, tumors of the endocrine part of the pancreas and tumors of the pituitary gland.

Etiopathogenesis
Defects (deletion, mutation) of the gene for menin protein. This gene is a a tumor suppressor gene. It is located on the 11th chromosome.

Clinical picture
Parts of MEN 1 can be: adrenal adenomas, carcinoid, subcutaneous lipomas, angiofibromas on the face, collagenomas, ...
 * 1) Primary hyperparathyroidism - occurs within the syndrome with a probability of 95-100% and is also the first manifestation.
 * 2) Tumors of the endocrine pancreas - can be afunctional or hormonally active - most often gastrinoma (60%) or insulinoma (20%).
 * 3) Pituitary tumors - almost always adenomas. They can be non-functional, in case of activity it is almost always a prolactinoma.

Diagnostics
Proof of at least two basic components of the syndrome, proof of diagnosis based on molecular biological examinations.

Therapy
It consists in the therapy of individual components.

Prognosis
Increased morbidity and mortality depends on early diagnosis and treatment of individual components.

Definition and Epidemiology
An autosomal dominantly inherited syndrome with a prevalence of 1–5 cases per 100,000 population. The components of the syndrome are: medullary carcinoma of the thyroid gland, pheochromocytoma, primary hyperparathyroidism.

Etiopathogenesis
Mutation of RET proto-oncogene located on the 10th chromosome.

Clinical picture

 * 1) Medullary thyroid carcinoma - usually manifests first, is highly malignant.
 * 2) Primary hyperparathyroidism - manifests in approximately 25%.
 * 3) Pheochromocytoma.

Differential diagnosis
Differentiation from other tumor syndromes. We will confirm the diagnosis by showing a mutation of the RET proto-oncogene.

Therapy
It consists in the therapy of individual components. Dispensary is important and preventive total thyroidectomy is indicated for offspring.

Prognosis
MEN 2A is a severe syndrome with increased morbidity and mortality. Early diagnosis, therapy of individual components and also which components of the syndrome are manifested are important.

Definition and Epidemiology
An autosomal dominantly inherited syndrome with a prevalence of 1–3 cases per 100,000 population. Components of the syndrome are: medullary carcinoma of the thyroid gland, pheochromocytoma, mucosal neuromas.

Etiopathogenesis
Mutation of the RET proto-oncogene located on chromosome 10.

Clinical picture

 * 1) Medullary thyroid carcinoma - present in 100% of cases.
 * 2) Pheochromocytoma - present in 50% of cases, often bilateral.
 * 3) Mucosal neuromas - in 100% of cases, marfanoid habitus (70%) and intestinal ganglioneuromas.

Diagnostics
Evidence of individual components of the syndrome and evidence of a RET proto-oncogene mutation.

Therapy
To prove the syndrome, preventive total thyroidectomy is indicated even before the manifestation of cancer, also for offspring. The therapy of individual components is also used, dispensary with active search and early diagnosis is important.

Prognosis
MEN 2B is a severe syndrome with increased morbidity and mortality. Early diagnosis, therapy of individual components and also which components of the syndrome are manifested are important.

Related Articles

 * Medullary thyroid carcinoma
 * Pheochromocytoma